Search

Your search keyword '"Bola, S"' showing total 196 results

Search Constraints

Start Over You searched for: Author "Bola, S" Remove constraint Author: "Bola, S"
196 results on '"Bola, S"'

Search Results

2. Gravity surveys using a mobile atom interferometer

4. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

5. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

6. A Multi-disciplinary Quality Improvement Initiative to Improve Timely Access to a Pediatric Tertiary Care Sleep Centre

8. Body composition and lung cancer-associated cachexia in TRACERx

9. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

10. Genomic–transcriptomic evolution in lung cancer and metastasis

11. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

12. Antibodies against endogenous retroviruses promote lung cancer immunotherapy

13. The evolution of lung cancer and impact of subclonal selection in TRACERx

14. Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

19. Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice

21. Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme

22. The potential for Treg-enhancing therapies in tissue, in particular skeletal muscle, regeneration

24. Treg cells require Izumo1R to regulate γδT cell-driven inflammation in the skin

25. Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities

26. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

27. A dynamic atlas of immunocyte migration from the gut

29. Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

30. EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia

33. IL-17A–producing γδT cells promote muscle regeneration in a microbiota-dependent manner

35. Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice

36. Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity

37. The potential for Treg-enhancing therapies in tissue, in particular skeletal muscle, regeneration.

38. TBET‐expressing Th1 CD4 + T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice

39. CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion

40. Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia

41. Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia

42. Rejection of adoptively transferred Eµ-TCL1 chronic lymphocytic leukemia cells in C57BL/6 substrains or knockout mouse lines

44. Interleukin-10 receptor signaling promotes the maintenance of a PD-1

47. P76.52 Liquid Biopsy and PET Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC

48. Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues

49. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

Catalog

Books, media, physical & digital resources